This is because to decide whether the court abused its discretion in awarding costs and
fees, the Eighth Circuit necessarily must decide if it was objectively reasonable for Pfizer to challenge the
joinder of these plaintiffs and the lack of personal jurisdiction over the out - of - state plaintiffs» claims.